Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Paraganglioma × Catecholamines × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Paraganglioma 1

Interventions

anlotinib 2 lutetium Lu 177 dotatate 1 Temozolomide 1 Catecholamines 1 90Y-octreotate, DOTA(0)-Tyr(3)-Thr(8)- 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05451134 2022-07-12

Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma

China National Center for Cardiovascular Diseases

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡